CD44v8-10 as a potential theranostic biomarker for targeting disseminated cancer cells in advanced gastric cancer
Abstract Gastric cancer is the third most common cause of cancer mortality, and the survival rate of stage IV advanced gastric cancer (AGC) patients with distant metastasis is very low. Thus, the detection and eradication of disseminated cancer cells by targeting cell surface molecules in AGC would...
Guardado en:
Autores principales: | Eun-Seok Choi, Hyunjin Kim, Hyung-Pyo Kim, Yongdoo Choi, Sung-Ho Goh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/57c5306b483b4325a372f9761049980d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics
por: Gul-e-Saba Chaudhry, et al.
Publicado: (2020) -
Spotlight on PSMA as a new theranostic biomarker for bladder cancer
por: Maria Maddalena Tumedei, et al.
Publicado: (2021) -
Chromatin accessibility of circulating CD8+ T cells predicts treatment response to PD-1 blockade in patients with gastric cancer
por: Hyun Mu Shin, et al.
Publicado: (2021) -
89Zr anti-CD44 immuno-PET monitors CD44 expression on splenic myeloid cells and HT29 colon cancer cells
por: Jin Won Park, et al.
Publicado: (2021) -
A Novel Therapeutic siRNA Nanoparticle Designed for Dual-Targeting CD44 and Gli1 of Gastric Cancer Stem Cells
por: Yao H, et al.
Publicado: (2020)